Astellas 1951-CL-0101
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Astellas Pharma Global Development, Inc
Start Date
July 13, 2020
End Date
March 13, 2024
Administered By
Duke Cancer Institute
Awarded By
Astellas Pharma Global Development, Inc
Start Date
July 13, 2020
End Date
March 13, 2024